Patient Number | Isolate | CTX-M15 | TEM-1 | PFGE |
---|---|---|---|---|
1 | 1 | Pos | Pos | No PFGE |
1 | 2 | Pos | Pos | No PFGE |
1 | 3 | Pos | Pos | 93.3% |
1 | 4 | Pos | Pos | |
1 | 5 | Pos | Pos | |
1 | 6 | No Growth | ||
2 | 1 | Pos | Neg | 100% |
2 | 2 | Pos | Neg | |
3 | 1 | No Growth | 97.1% | |
3 | 2 | No Growth | ||
4 | 1 | Pos | Neg | 100% |
4 | 2 | Pos | Neg | |
5 | 1 | Pos | Neg | 100% |
5 | 2 | Pos | Neg | |
6 | 1 | Pos | Neg | 100% |
6 | 2 | Pos | Neg | |
7 | 1 | Pos | Neg | 100% |
7 | 2 | Neg | Neg | |
8 | 1 | Pos | Neg | 100% |
8 | 2 | Pos | Neg | |
8 | 3 | Pos | Neg | |
9 | 1 | Pos | Pos | 55.3% |
9 | 2 | No Growth | ||
9 | 3 | Pos | Pos | |
9 | 4 | Pos | Pos | |
9 | 5 | Pos | Pos | |
9 | 6 | Pos | Pos | |
10 | 1 | Pos | Pos | 60.3% |
10 | 2 | Pos | Neg | |
10 | 3 | Neg | Pos | |
10 | 4 | Neg | Pos | |
11 | 1 | Pos | Pos | 59.8% |
11 | 2 | Pos | Pos | |
11 | 3 | Neg | Neg | |
12 | 1 | Pos | Neg | 60% |
12 | 2 | Neg | Neg | |
13 | 1 | Neg | Neg | 60.9% |
13 | 2 | Neg | Neg | |
14 | 1 | Pos | Neg | 42.9% |
14 | 2 | Pos | Pos | |
15 | 1 | Pos | Pos | 100% |
15 | 2 | Neg | Neg | |
15 | 3 | Neg | Neg | |
16 | 1 | Pos | Neg | 97.1% |
16 | 2 | Pos | Neg | |
16 | 3 | Pos | Neg | |
17 | 1 | Pos | Neg | 100% |
17 | 2 | Pos | Neg | |
18 | 1 | Pos | Pos | 100% |
18 | 2 | Neg | Pos | |
19 | 1 | Pos | Neg | 100% |
19 | 2 | Pos | Neg | |
20 | 1 | Pos | Neg | 100% |
20 | 2 | Pos | Pos | |
21 | 1 | Pos | Neg | 56.6% |
21 | 2 | Pos | Pos | |
22 | 1 | Pos | Neg | 63.4% |
22 | 2 | Neg | Neg |